PIQ-PHARMA is launching a new pharmaceutical product Profitus® tablets.

LLC "PIQ-PHARMA" announces the introduction of the first and only levodropropizine medication in tablet form on the Russian market — Profitus® tablets 60 mg, available in #10 and #20 packs.

Profitus® contains levodropropizine, which exhibits antitussive action at the level of the respiratory tract and provides additional anti-inflammatory and antihistamine effects. Thus, the medication has a triple action against non-productive cough, making it a recommended effective remedy for the symptomatic treatment of dry cough of various etiologies in adults and children.

The active ingredient of the Profitus® medication, levodropropizine, is included in the Clinical Guidelines for the treatment of acute respiratory viral infections (ARVI) in adults, as well as for acute and chronic bronchitis, and in the Temporary Methodological Recommendations for the prevention and treatment of coronavirus infection.

The expansion of the Profitus® product line with a tablet form will allow for a broader consumer base and enhance brand loyalty among the medical community and consumers who prefer cough treatments in tablet form.